CEACAM5 and cancer: The present study explored the diagnostic performance of the tumor markers CEA and CA19-9 in GI and whole-body cancer screening, and clearly demonstrated their very low sensitivities and PPV even when targeting multiple GI and whole-body cancers instead of single-organ cancers.